Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    NCT02925234
Previous Study | Return to List | Next Study

The Drug Rediscovery Protocol (DRUP Trial) (DRUP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02925234
Recruitment Status : Recruiting
First Posted : October 5, 2016
Last Update Posted : February 17, 2020
Sponsor:
Collaborators:
Amgen
AstraZeneca
Bayer
Bristol-Myers Squibb
Novartis
Roche Pharma AG
Merck Sharp & Dohme Corp.
Boehringer Ingelheim
Ipsen
Eisai Inc.
Pfizer
Clovis Oncology, Inc.
Information provided by (Responsible Party):
The Netherlands Cancer Institute

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : August 2022
Estimated Study Completion Date : December 2022